https://news.medxy.ai/zh/benefits-of-thrombectomy/Medxy AIzh2026-04-19T23:44:07-07:00即使最大的卒中核心区域也可能从取栓术中获益，LASTE 附属分析表明 https://news.medxy.ai/ja/thrombectomy-benefits/Medxy AIja2026-04-19T23:40:22-07:00最大の脳梗塞コアでも血栓回収術が有益、LASTE補助解析が示唆 https://news.medxy.ai/vi/thrombectomy-benefits-analysis/Medxy AIvi2026-04-19T23:36:30-07:00Ngay cả những cốt lõi đột quỵ lớn nhất cũng có thể hưởng lợi từ thrombectomy, phân tích phụ trợ của LASTE cho thấy https://news.medxy.ai/largest-stroke-cores-thrombectomy/Medxy AIen2026-04-19T23:31:23-07:00Even the Largest Stroke Cores May Benefit from Thrombectomy, LASTE Ancillary Analysis Suggests https://news.medxy.ai/zh/parkinsons-motor-function-connectivity/Medxy AIzh2026-04-19T23:24:56-07:00帕金森病运动功能下降前后皮质纹状体连接重组 https://news.medxy.ai/ja/parkinsons-motor-function-reorganization/Medxy AIja2026-04-19T23:23:04-07:00パーキンソン病の運動機能低下前後における大脳皮質-尾状核回路の再編成 https://news.medxy.ai/vi/corticostriatal-reorganization-parkinsons/Medxy AIvi2026-04-19T23:19:48-07:00Kết nối corticostriatal tái tổ chức trước và sau khi suy giảm vận động trong bệnh Parkinson https://news.medxy.ai/corticostriatal-connectivity-parkinson/Medxy AIen2026-04-19T23:12:05-07:00Corticostriatal Connectivity Reorganizes Before and After Motor Decline in Parkinson Disease https://news.medxy.ai/zh/dash-diet-cognition-risk/Medxy AIzh2026-04-19T09:35:52-07:00DASH饮食及其他健康饮食模式与美国大型队列中较低的认知衰退风险相关 https://news.medxy.ai/ja/dash-diet-cognitive-health/Medxy AIja2026-04-19T09:34:00-07:00DASHおよびその他の健康的な食事パターンが大規模な米国コホートでの認知機能低下リスクの低下と関連 https://news.medxy.ai/vi/dash-diet-cognitive-health/Medxy AIvi2026-04-19T09:31:41-07:00Chế độ ăn DASH và các chế độ ăn lành mạnh khác liên quan đến nguy cơ suy giảm nhận thức thấp hơn trong các nhóm lớn ở Hoa Kỳ https://news.medxy.ai/dash-healthy-diets-cognition/Medxy AIen2026-04-19T09:27:45-07:00DASH and Other Healthy Diets Linked to Lower Cognitive Decline Risk in Large U.S. Cohorts https://news.medxy.ai/zh/guidelines-reduce-workload/Medxy AIzh2026-04-19T09:17:35-07:00限制性甲状腺偶发瘤指南大幅减少工作量，但可能漏诊少量低风险癌症 https://news.medxy.ai/ja/guideline-reduces-workload/Medxy AIja2026-04-19T09:16:08-07:00甲状腺偶发瘤的限制性指南大幅减少工作量，但会漏诊少量低风险癌症 https://news.medxy.ai/vi/incidentaloma-guidelines/Medxy AIvi2026-04-19T09:13:35-07:00Hướng dẫn Hạn chế về Incidentaloma Giáp Giảm Nặng Gánh Công Việc nhưng Bỏ Qua Một Số Ca Ung Thư Rủi Ro Thấp https://news.medxy.ai/thyroid-incidentaloma-guidelines/Medxy AIen2026-04-19T09:08:48-07:00Restrictive Thyroid Incidentaloma Guidelines Cut Workload Dramatically but Miss a Small Number of Low-Risk Cancers https://news.medxy.ai/genetic-variant-diet-glucose/Medxy AIen2026-04-18T20:44:23-07:00Genetic Variant Modulates Dietary Impact on Glucose Control: Inuit Study Reveals Key Insights https://news.medxy.ai/ata-risk-stratification-papillary-thyroid/Medxy AIen2026-04-18T20:41:18-07:00Validation of the 2025 ATA Risk Stratification System in a Cohort of Patients with Papillary Thyroid Carcinoma https://news.medxy.ai/2025-ata-risk-stratification-thyroid-cancer/Medxy AIen2026-04-18T20:28:01-07:002025 ATA Risk Stratification for Papillary Thyroid Cancer: Validation Study Reveals Significant Reclassification Shifts https://news.medxy.ai/zh/lbbp-vs-bivp-death-rate-reduction/Medxy AIzh2026-04-18T15:21:29-07:00LBBP优于BiVP：3年内死亡或心力衰竭住院率降低74% https://news.medxy.ai/ja/lbbp-vs-bivp-risk-decrease/Medxy AIja2026-04-18T15:20:26-07:00LBBPがBiVPを上回る：3年間で死亡または心不全入院のリスクが74%減少 https://news.medxy.ai/vi/lbbp-vs-bivp-heart-failure/Medxy AIvi2026-04-18T15:17:25-07:00LBBP vượt trội hơn BiVP: Giảm 74% tỷ lệ tử vong hoặc nhập viện do suy tim sau 3 năm https://news.medxy.ai/lbbp-vs-bivp-hospitalization-reduction/Medxy AIen2026-04-18T15:14:56-07:00LBBP Outperforms BiVP: 74% Reduction in Death or Heart Failure Hospitalization at 3 Years https://news.medxy.ai/zh/cardiovascular-risk-increase/Medxy AIzh2026-04-18T14:11:09-07:00心血管风险增加六倍：子痫早期产后威胁亟需临床关注 https://news.medxy.ai/ja/cardiovascular-risk-preeclampsia/Medxy AIja2026-04-18T14:09:39-07:00心血管リスクが6倍に: 産褥期早期の子癇前症の脅威は緊急の臨床的な注意を必要とする https://news.medxy.ai/vi/high-cardiac-risk/Medxy AIvi2026-04-18T14:07:40-07:00Nguy cơ tim mạch cao gấp sáu lần: Đe dọa sớm sau sinh của tiền sản giật đòi hỏi sự chú ý lâm sàng khẩn cấp https://news.medxy.ai/eclampsia-postpartum-risk/Medxy AIen2026-04-18T14:04:03-07:00Six-Fold Higher Cardiovascular Risk: Eclampsia’s Early Postpartum Threat Demands Urgent Clinical Attention https://news.medxy.ai/zh/no-clear-winner-glp-1-sglt2-benefits/Medxy AIzh2026-04-18T13:39:35-07:00无明显胜者：真实世界证据显示GLP-1受体激动剂和SGLT2抑制剂在2型糖尿病中提供相当的心血管获益 https://news.medxy.ai/ja/no-clear-winner-glp-1-sglt2/Medxy AIja2026-04-18T13:37:44-07:00明確な勝者はいない：実世界の証拠がGLP-1受容体作動薬とSGLT2阻害薬が2型糖尿病で同等の心血管効果を示す https://news.medxy.ai/vi/no-clear-winner/Medxy AIvi2026-04-18T13:33:25-07:00Không có người chiến thắng rõ ràng: Bằng chứng thực tế cho thấy GLP-1RAs và SGLT2 Inhibitors mang lại lợi ích tim mạch tương đương trong bệnh đái tháo đường tuýp 2 https://news.medxy.ai/glp-1ra-vs-sglt2-benefits/Medxy AIen2026-04-18T13:30:30-07:00No Clear Winner: Real-World Evidence Shows GLP-1RAs and SGLT2 Inhibitors Deliver Comparable Cardiovascular Benefits in Type 2 Diabetes https://news.medxy.ai/zh/wnt5a-actin-imbalance-lmna-heart-disease/Medxy AIzh2026-04-18T12:18:37-07:00突破性研究揭示 WNT5a 驱动的肌动蛋白失调是 LMNA 相关心脏疾病的中心机制 https://news.medxy.ai/ja/wnt5a-actin-disruption-lmna-heart-disease/Medxy AIja2026-04-18T12:16:51-07:00革新的研究揭示WNT5a驱动的肌动蛋白失调是LMNA相关心脏疾病的中心机制 https://news.medxy.ai/vi/wnt5a-actin-disruption-cardiac-disease/Medxy AIvi2026-04-18T12:15:26-07:00Nghiên cứu đột phá tiết lộ sự mất điều chỉnh actin do WNT5a là cơ chế cốt lõi trong bệnh tim liên quan đến LMNA https://news.medxy.ai/wnt5a-actin-dysregulation-cardio/Medxy AIen2026-04-18T12:12:26-07:00Breakthrough Study Reveals WNT5a-Driven Actin Dysregulation as Core Mechanism in LMNA-Related Cardiac Disease https://news.medxy.ai/zh/fdg-pet-survival-breast-cancer/Medxy AIzh2026-04-18T11:59:00-07:00早期FDG-PET预测转移性乳腺癌生存结果：IMPACT-MBC试验揭示快速反应成像作为强大预后工具 https://news.medxy.ai/ja/fdg-pet-breast-cancer-survival/Medxy AIja2026-04-18T11:57:51-07:00早期FDG-PET予測転移性乳がんの生存結果：IMPACT-MBC試験、迅速反応イメージングを強力な予後ツールとして明らかにする https://news.medxy.ai/vi/fdg-pet-breast-cancer-prediction/Medxy AIvi2026-04-18T11:56:13-07:00FDG-PET sớm dự đoán kết quả sống sót trong ung thư vú di căn: Thử nghiệm IMPACT-MBC tiết lộ hình ảnh đáp ứng nhanh là công cụ tiên lượng mạnh mẽ https://news.medxy.ai/early-fdg-pet-survival/Medxy AIen2026-04-18T11:53:14-07:00Early FDG-PET Predicts Survival Outcomes in Metastatic Breast Cancer: IMPACT-MBC Trial Reveals Rapid Response Imaging as a Powerful Prognostic Tool